Clinical Biochemistry
A safe and reliable non-invasive prenatal screening test for peace of mind during pregnancy
Clinical Biochemistry
A safe and reliable non-invasive prenatal screening test for peace of mind during pregnancy
Clinical Biochemistry
A safe and reliable non-invasive prenatal screening test for peace of mind during pregnancy
Humans have 23 pairs of chromosomes (46 in total), which are strands of DNA and proteins containing the genetic information necessary for the structure and function of the body.
Chromosomal abnormalities are conditions where the number and/or structure of chromosomes differ from the normal arrangement. Trisomies, in particular, occur where three copies of a chromosome are present instead of the usual two. For example, Trisomy 21 involves three copies of chromosome 21 and is associated with Down syndrome.
Early detection of a chromosomal abnormality enables future parents to plan appropriate obstetric and gynaecological management during pregnancy and childbirth.
DuoScreen® is a screening test designed to identify pregnancies at increased risk of foetal chromosomal abnormalities. It is a non-invasive prenatal test that poses no risk to either the mother or the foetus.
Valid between 10 and 13 weeks of pregnancy.
Assesses the risk of Trisomy 21, Trisomy 18, and Trisomy 13.
The test includes the measurement of two maternal serum proteins, PAPP-A and Free β-HCG, along with an ultrasound measurement of the foetal Nuchal Translucency (NT). It calculates a “risk index” based on the protein levels and the NT measurement, providing an estimate of the likelihood that the foetus may have chromosomal abnormalities.
Valid between 15 and 18 weeks of pregnancy.
Assesses the risk of Trisomy 21, Trisomy 18, and Trisomy 13.
The test includes the measurement of two maternal serum proteins, AFP and Free β-HCG, along with ultrasound measurements of the foetal Femur Length (FL) and Biparietal Diameter (BPD). It calculates a “risk index” based on the protein levels and ultrasound measurements, providing an estimate of the likelihood that the foetus may have chromosomal abnormalities.
